pramipexole has been researched along with idebenone in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (idebenone) | Trials (idebenone) | Recent Studies (post-2010) (idebenone) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 448 | 46 | 207 |
| Protein | Taxonomy | pramipexole (IC50) | idebenone (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 7 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 3 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 5 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.8 | |
| NAD-dependent protein deacetylase | Schistosoma mansoni | 1.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
1 other study(ies) available for pramipexole and idebenone
| Article | Year |
|---|---|
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |